Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
Kizilors A, Crisà E, Lea N, Passera R, Mian S, Anwar J, Best S, Nicolini FE, Ireland R, Aldouri M, Pocock C, Corbett T, Gale R, Bart-Smith E, Weston-Smith S, Wykes C, Kulasekararaj A, Jackson S, Harrington P, McLornan D, Raj K, Pagliuca A, Mufti GJ, de Lavallade H. Kizilors A, et al. Among authors: pagliuca a. Lancet Haematol. 2019 May;6(5):e276-e284. doi: 10.1016/S2352-3026(19)30027-4. Lancet Haematol. 2019. PMID: 31036317
Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.
Parker JE, Shafi T, Pagliuca A, Mijovic A, Devereux S, Potter M, Prentice HG, Garg M, Yin JA, Byrne J, Russell NH, Mufti GJ. Parker JE, et al. Among authors: pagliuca a. Br J Haematol. 2002 Oct;119(1):144-54. doi: 10.1046/j.1365-2141.2002.03796.x. Br J Haematol. 2002. PMID: 12358919 Free article.
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.
Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S, Mufti GJ. Ho AY, et al. Among authors: pagliuca a. Blood. 2004 Sep 15;104(6):1616-23. doi: 10.1182/blood-2003-12-4207. Epub 2004 Apr 1. Blood. 2004. PMID: 15059843 Free article. Clinical Trial.
T-cell lymphoblastic lymphoma presenting as an intra-muscular mass.
Lim Z, Gupta S, Salisbury JR, Elias D, Venkatram NK, Mufti GJ, Pagliuca A. Lim Z, et al. Among authors: pagliuca a. Br J Haematol. 2006 Mar;132(5):537. doi: 10.1111/j.1365-2141.2005.05901.x. Br J Haematol. 2006. PMID: 16445824 Free article. No abstract available.
255 results